葡萄膜炎治療市場：依治療方法、疾病類型、通路和地區分類

Uveitis Treatment Market, By Treatment Type, By Disease type, By Distribution Channel, By Geography

出版日期: 2026年04月06日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，葡萄膜炎治療市場規模將達到 9.06 億美元，到 2033 年將達到 13.89 億美元。預計從 2026 年到 2033 年，該市場將以 6.3% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	9.06億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.30%	2033年市場規模預測：	13.89億美元

葡萄膜炎是指眼內葡萄膜的發炎。葡萄膜是眼球的中階，由虹膜、睫狀體和脈絡膜三部分組成。葡萄膜炎的原因多種多樣，包括發炎性疾病、眼部外傷、病毒、細菌和真菌等微生物感染，以及接觸強酸和殺蟲劑等有毒化學物質。然而，在許多情況下，病因不明。葡萄膜炎多發於20至50歲的人。根據發炎部位的不同，葡萄膜炎可分為三種類型，其中包括前葡萄膜炎，其發炎主要涉及虹膜。前葡萄膜炎是最常見的類型。

市場動態

預計在預測期內，市場新參與企業推出新產品的數量增加將推動全球葡萄膜炎治療市場的發展。例如，2022年2月7日，總部位於喬治亞的生物製藥公司Alimera Sciences宣佈在西班牙推出其葡萄膜炎治療產品ILUVIEN（Fluocinolone Acetonide體內植入）。 ILUVIEN是一家專注於處方眼科藥物商業化和研發的公司。 ILUVIEN是一種緩釋型玻璃體內植入劑，已獲准在歐洲用於治療現有治療方法無法有效控制的慢性糖尿病黃斑部水腫（DME）引起的視力喪失，並預防核准眼後部的複發性非感染性葡萄膜炎（NIPU）的複發。 ILUVIEN植入36個月內以亞微克單位釋放Fluocinolone Acetonide，使患者能夠在更長的治療間隔內維持更長時間的視力。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球葡萄膜炎治療市場主要參與者的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球葡萄膜炎治療市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球葡萄膜炎治療市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

AbbVie
Novartis AG
Bausch Health Companies Inc.
Galapagos NV
EyePoint Pharmaceuticals, Inc.
Clearside Biomedical
Tarsier Pharma Ltd
Santen Pharmaceutical Co., Ltd.
Bausch &Lomb Incorporated
Sanofi
Regeneron Pharmaceuticals, Inc.
Alimera Sciences

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI1094

Uveitis Treatment Market is estimated to be valued at USD 906 Mn in 2026 and is expected to reach USD 1,389 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 906 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 1,389 Mn

Uveitis refers to inflammation caused in the uvea of the eye. A uvea is the middle layer of the eye that consists of three components namely iris, cilliary body, and the choroid. Uveitis is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides. However, in many cases the cause of this condition remains unknown. It is also found to be effecting people belonging to the age group of 20-50 years. The condition is classified based on the location of inflammation in the uvea and is categorized in three types including anterior uveitis that causes inflammation in the iris and is the most commonly encountered type.

Market Dynamics

Increasing product launches by market players is expected to drive the global uveitis treatment market over the forecast period. For instance, in February 7, 2022, Alimera Sciences which is a biopharmaceutical company based in Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, has announced that it has announced Launch of ILUVIEN (fluocinolone acetonide intravitreal implant) for Uveitis in Spain. ILUVIEN is a sustained release intravitreal implant approved for use in Europe to treat vision loss brought on by chronic diabetic macular edema (DME), which is thought to be under responsive to current treatments, as well as to prevent relapse in cases of recurrent non-infectious uveitis affecting the posterior segment of the eye (NIPU). ILUVIEN is made to deliver sub-microgram quantities of the corticosteroid fluocinolone acetonide for 36 months, which helps patients preserve their vision for longer between treatments.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global uveitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Sanofi and Regeneron Pharmaceuticals, Inc., Alimera Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global uveitis treatment market

Market Segmentation

By Treatment Type Insights (Revenue, USD Mn, 2021 - 2033)
- Corticosteroids
- Immunosuppressant
- Monoclonal Antibodies
- Cycloplegic Agents
- Antibiotics
- Antivirals
- Antifungal
- Analgesics
By Disease Type Insights (Revenue, USD Mn, 2021 - 2033)
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Pan uveitis
By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players in the Uveitis Treatment Market
- AbbVie
- Novartis AG
- Bausch Health Companies Inc.
- Galapagos NV
- EyePoint Pharmaceuticals, Inc.
- Clearside Biomedical
- Tarsier Pharma Ltd
- Santen Pharmaceutical Co., Ltd.
- Bausch & Lomb Incorporated
- Sanofi
- Regeneron Pharmaceuticals
- Alimera Sciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pipeline Analysis
PEST Analysis

4. Global Uveitis Treatment Market, By Treatment Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Immunosuppressant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cycloplegic Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Antivirals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Antifungal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Uveitis Treatment Market, By Disease Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Anterior Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Posterior Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Intermediate Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pan uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Uveitis Treatment Market, By Distribution Channel, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Drug Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Uveitis Treatment Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

AbbVie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Galapagos NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EyePoint Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Clearside Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Tarsier Pharma Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Santen Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bausch & Lomb Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alimera Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies